Neutrophil-lymphocyte ratio in patients with ankylosing spondylitis

Year 2014, Volume: 3 Issue: 1, 16 - 20, 01.01.2014

Mustafa Özşahin Hilmi Demirin Taner Uçgun Fatih Ermiş Özlem Admış Safinaz Ataoğlu

https://doi.org/10.5505/abantmedj.2014.16878

Abstract

OBJECTIVE: The purpose of the present study is to determine the association between neutrophil-lymphocyte ratio NLR and inflammation in ankylosing spondylitis AS . METHODS: Forty patients with ankylosing spondylitis and 30 healthy volunteers were included in the study. All data were obtained from patient registry database from in-patient and out-patient clinics. Detailed physical examination, and Bath Ankylosing Spondylitis Disease Activity Index BASDAI were recorded. Complete blood count CBC , CRP and ESR were performed recorded as laboratory tests in all participants. Lymphocyte and neutrophil counts were measured as part of the automated CBC.RESULTS: The CRP, which is an acute-phase reactant, and ESR were significantly higher in the patient group than those in the control group p0.05 .CONCLUSION: We observed that NLR levels weren’t significantly higher in AS patients compared to healthy individuals. NLR hasn’t seem a reasonable measure to detect systemic inflammation in AS patients. We believe that our preliminary results need to be complemented with further studies.

Keywords

Neutrophil-lymphocyte ratio, ankylosing spondylitis, inflammation, disease activity

Ankilozan spondilit hastalarında nötrofil-lenfosit oranı

Abstract

AMAÇ: Bu çalışmanın amacı, ankilozan spondilit AS hastalarındaki inflamasyon ile nötrofil-lenfosit oranı NLO arasındaki ilişkiyi belirlemektir.YÖNTEMLER: Ankilozan spondilit tanılı 40 hasta ve 30 sağlıklı gönüllü çalışmaya dahil edildi. Tüm veriler yatan ve poliklinik hasta kayıt veritabanından elde edildi. Tüm olguların Bath Ankilozan Spondilit Hastalık Aktivite İndeksi BASDAI , tam kan sayımı TKS , CRP ve ESH’ı da kapsıyan ayrıntılı fizik muayene ve laboratuvar bulguları kaydedildi. Lenfosit ve nötrofil sayısı otomatik TKS’nin bir parçası olarak ölçüldü.BULGULAR: Akut-faz reaktanı olan CRP ve ESH kontrol grubuna göre hasta grubunda anlamlı olarak daha yüksekti p 0.05 .SONUÇ: Bu çalışmada NLO düzeylerinin AS hastalarında sağlıklı bireylere göre anlamlı olarak yüksek olmadığı görüldü. Bu sonuç NLO’nun AS hastalarında sistemik inflamasyonu değerlendirmede uygun bir ölçü birimi olmadığını götermektedir. Bizim elde ettiğimiz bu ön sonuçların daha ileri çalışmalarla tamamlanması gerektiğine inanıyoruz.

Keywords

Nötrofil-lenfosit oranı, ankilozan spondilit, enflamasyon, hastalık aktivitesi

References

• 1. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896-907.
• 2. Elewaut D, Matucci-Cerinic M. Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Rheumatology (Oxford) 2009; 48: 1029-35.
• 3. Calin A, Brophy S, Blake D. Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet 1999; 354: 1687-90.
• 4. Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. Joint Bone Spine 2007; 74: 249-53.
• 5. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14.
• 6. Tasoglu I, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-Lymphocyte Ratio and the Platelet-Lymphocyte Ratio Predict the Limb Survival in Critical Limb Ischemia. Clin Appl Thromb Hemost 2013 Feb 6. [Epub ahead of print]
• 7. Biyik M, Ucar R, Solak Y, Gungor G, Polat I, Gaipov A, Cakir OO, Ataseven H, Demir A, Turk S, Polat H. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2013; 25: 435-41.
• 8. Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, Sencan M. Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int 2013; 2013: 185317. Epub 2013 Jun 20.
• 9. Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, Acarturk G. As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio. Inflammation 2013 Jun 21. [Epub ahead of print]
• 10. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
• 11. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, Hillis GS. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010; 105: 186-91.
• 12. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11: 55-9.
• 13. Oztürk S, Erdem A, Ozlü MF, Ayhan S, Erdem K, Ozyaşar M, Aslantaş Y, Yazıcı M. Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Turk Kardiyol Dern Ars 2013; 41: 284-9.
• 14. Gazi E, Bayram B, Gazi S, Temiz A, Kirilmaz B, Altun B, Barutcu A. Prognostic Value of the Neutrophil-Lymphocyte Ratio in Patients With ST-Elevated Acute Myocardial Infarction. Clin Appl Thromb Hemost 2013 Jun 9. [Epub ahead of print]
• 15. Ayhan SS, Oztürk S, Erdem A, Ozlü MF, Ozyaşar M, Erdem K, Yazıcı M. Relation of neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia. Turk Kardiyol Dern Ars 2013; 41: 185-90.
• 16. Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res 2013; 33: 3291-4.
• 17. de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. Prognostic Impact of Preoperative NeutrophilTo-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma. J Urol 2013 Jul 2. [Epub ahead of print]
• 18. Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, L Ress A, Kornprat P, A Zoughbi W, Seggewies FS, Lackner C, Stojakovic T, Samonigg H, Hoefler G, Pichler M. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013; 109: 416-21. Epub 2013 Jun 25.
• 19. Dhillon V, Woo P, Isenberg D. Amyloidosis in the rheumatic diseases. Ann Rheum Dis 1989; 48: 696-701.
• 20. Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soytürk M, Akar S, Tunca M, Hawkins PN. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-50.
• 21. Her M, Kavanaugh A. Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors. Curr Opin Rheumatol 2013; 25: 455-9.
• 22. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012; 5: 2.
• 23. Celikbilek M, Dogan S, Ozbakır O, Zararsız G, Kücük H, Gürsoy S, Yurci A, Güven K, Yücesoy M. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 2013; 27: 72-6.
• 24. Mielants H, De Keyser F, Baeten D, Van den Bosch F. Gut inflammation in the spondyloarthropathies. Curr Rheumatol Rep 2005; 7: 188- 94.